🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Obecholic acid is a modified bile acid and Farnesoid X receptor (FXR) agoni...
Status
Completed
Location
Beijing Friendship Hospital
Start Date
2021-09-23
Trial ID
NCT05450887
Treatments Being Tested
The main purpose of this study is to see whether heavy drinking will interf...
Status
Completed
Location
Indiana University
Start Date
2016-04
Trial ID
NCT02654236
Treatments Being Tested
The main objectives of the study were to assess the effects of Obeticholic ...
Status
Completed
Location
UC Davis Medical Center
Start Date
2012-01
Trial ID
NCT01473524
Treatments Being Tested
This study was conducted on patients presenting to Mayo Hospital, Lahore fr...
Status
Completed
Location
King Edward Medical University, Mayo Hospital, Lahore
Start Date
2023-08-24
Trial ID
NCT07104786
Treatments Being Tested
This was a phase 2, double-blind (DB), placebo-controlled trial in particip...
Status
Completed
Location
St. Joseph's Hospital & Medical Center
Start Date
2015-02-09
Trial ID
NCT02177136
Treatments Being Tested
This is a Phase 2, multicenter, open-label, single dose and multi-dose, dos...
Status
Terminated
Location
Clinques University Saint-Luc
Start Date
2015-07-01
Trial ID
NCT05321524
The primary hypothesis was that obeticholic acid (OCA) will cause a reducti...
Status
Completed
Location
Henry Ford
Start Date
2008-01-17
Trial ID
NCT00570765
Treatments Being Tested
Primary Biliary Cholangitis (PBC) is a serious, life-threatening, bile acid...
Status
Terminated
Location
Mayo Clinic Arizona
Start Date
2014-12-26
Trial ID
NCT02308111
Treatments Being Tested
This Phase 2, double-blind, randomized, placebo-controlled, multicenter stu...
Status
Completed
Location
St. Joseph's Hospital and Medical Center
Start Date
2015-12-04
Trial ID
NCT02633956
Treatments Being Tested
This Phase 4, randomized, double-blind, placebo-controlled study will evalu...
Status
Terminated
Location
Inland Empire Liver Foundation
Start Date
2018-06-22
Trial ID
NCT03633227
Treatments Being Tested